WA
NVO

WealthTrust Axiom’s Novo Nordisk NVO Stock Holding History

WealthTrust Axiom’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.92M Buy
81,667
+18,007
+28% +$774K 0.87% 29
2026
Q1 		$2.34M Buy
63,660
+17,597
+38% +$834K 0.58% 44
2025
Q4 		$2.34M Buy
46,063
+10,073
+28% +$515K 0.6% 38
2025
Q3 		$2M Buy
35,990
+17,395
+94% +$1.02M 0.54% 43
2025
Q2 		$1.28M Buy
18,595
+9,526
+105% +$648K 0.38% 66
2025
Q1 		$630K Buy
+9,069
New +$749K 0.19% 108

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

WealthTrust Axiom's NVO Position: Q2 2026 in Review

WealthTrust Axiom increased its Novo Nordisk (NVO) stake by 28% in Q2 2026, buying an estimated $774K and bringing the position to 81,667 shares worth $3.92M. The position accounts for 0.87% of the portfolio, ranked #29.

WealthTrust Axiom first reported a position in NVO in Q1 2025 and has held it in 6 quarters since. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • WealthTrust Axiom held 81,667 shares of Novo Nordisk worth $3.92M as of Q2 2026.
  • WealthTrust Axiom bought 18,007 Novo Nordisk shares in Q2 2026, an estimated $774K.
  • Novo Nordisk made up 0.87% of WealthTrust Axiom's portfolio in Q2 2026, its #29 holding.
  • WealthTrust Axiom first reported a position in Novo Nordisk in Q1 2025 and has held it in 6 quarters since.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on WealthTrust Axiom's 13F filing for Q2 2026, filed 11 Aug 2026.